DAPTOMYCIN for Atrial fibrillation: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 5 adverse event reports in the FDA FAERS database where DAPTOMYCIN was used for Atrial fibrillation.
Most Reported Side Effects for DAPTOMYCIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 791 | 8.8% | 123 | 360 |
| Drug ineffective | 658 | 7.3% | 212 | 329 |
| Product use in unapproved indication | 654 | 7.2% | 29 | 152 |
| Eosinophilic pneumonia | 575 | 6.4% | 78 | 349 |
| Acute kidney injury | 501 | 5.6% | 81 | 351 |
| Blood creatine phosphokinase increased | 461 | 5.1% | 25 | 205 |
| Pyrexia | 447 | 5.0% | 28 | 277 |
| Eosinophilia | 405 | 4.5% | 35 | 288 |
| Rhabdomyolysis | 383 | 4.2% | 26 | 264 |
| Drug reaction with eosinophilia and systemic symptoms | 307 | 3.4% | 26 | 198 |
| Chills | 288 | 3.2% | 1 | 75 |
| Rash | 288 | 3.2% | 22 | 146 |
| Interstitial lung disease | 280 | 3.1% | 40 | 196 |
| Thrombocytopenia | 242 | 2.7% | 66 | 176 |
| Pneumonitis | 216 | 2.4% | 18 | 121 |
Other Indications for DAPTOMYCIN
Staphylococcal infection (1,014)
Product used for unknown indication (859)
Osteomyelitis (635)
Infection (613)
Staphylococcal bacteraemia (511)
Endocarditis (506)
Enterococcal infection (416)
Device related infection (405)
Bacteraemia (380)
Sepsis (298)
Other Drugs Used for Atrial fibrillation
RIVAROXABAN (52,584)
DABIGATRAN ETEXILATE (20,492)
APIXABAN (10,500)
AMIODARONE (9,083)
WARFARIN (8,680)
EDOXABAN (3,855)
ASPIRIN (2,993)
DOFETILIDE (2,439)
PRADAXA (2,325)
METOPROLOL (1,542)